Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 15 studies | 24% ± 8% | |
| classical monocyte | 6 studies | 27% ± 7% | |
| retinal rod cell | 6 studies | 25% ± 6% | |
| endothelial cell | 6 studies | 22% ± 5% | |
| macrophage | 5 studies | 21% ± 5% | |
| non-classical monocyte | 4 studies | 18% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 18% ± 1% | |
| epithelial cell | 4 studies | 37% ± 14% | |
| CD4-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| conventional dendritic cell | 3 studies | 28% ± 10% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 3% | |
| connective tissue cell | 3 studies | 22% ± 5% | |
| myofibroblast cell | 3 studies | 20% ± 4% | |
| pericyte | 3 studies | 18% ± 1% | |
| smooth muscle cell | 3 studies | 17% ± 0% | |
| plasma cell | 3 studies | 30% ± 14% | |
| mucus secreting cell | 3 studies | 18% ± 2% | |
| ciliated cell | 3 studies | 28% ± 8% | |
| oligodendrocyte | 3 studies | 22% ± 4% | |
| plasmacytoid dendritic cell | 3 studies | 20% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 3547.81 | 459 / 459 | 100% | 29.83 | 1118 / 1118 |
| esophagus | 100% | 2610.72 | 1445 / 1445 | 100% | 14.37 | 183 / 183 |
| ovary | 100% | 3048.72 | 180 / 180 | 100% | 19.49 | 430 / 430 |
| lung | 100% | 3853.25 | 578 / 578 | 100% | 18.94 | 1153 / 1155 |
| prostate | 100% | 3380.68 | 245 / 245 | 100% | 25.76 | 501 / 502 |
| stomach | 100% | 2774.38 | 359 / 359 | 99% | 15.89 | 284 / 286 |
| intestine | 100% | 3061.11 | 966 / 966 | 99% | 15.53 | 523 / 527 |
| brain | 100% | 2072.11 | 2629 / 2642 | 100% | 16.21 | 703 / 705 |
| skin | 100% | 6015.61 | 1808 / 1809 | 99% | 27.14 | 468 / 472 |
| pancreas | 100% | 2663.79 | 328 / 328 | 99% | 15.96 | 176 / 178 |
| thymus | 100% | 3341.60 | 653 / 653 | 99% | 16.32 | 598 / 605 |
| bladder | 100% | 2948.05 | 21 / 21 | 98% | 15.47 | 496 / 504 |
| kidney | 100% | 2711.67 | 89 / 89 | 98% | 16.52 | 885 / 901 |
| uterus | 100% | 3274.28 | 170 / 170 | 98% | 14.84 | 448 / 459 |
| adrenal gland | 100% | 4329.52 | 258 / 258 | 97% | 14.39 | 224 / 230 |
| liver | 100% | 2840.50 | 226 / 226 | 94% | 12.03 | 383 / 406 |
| adipose | 100% | 3916.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3547.40 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2859.35 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.80 | 1 / 1 |
| muscle | 99% | 2329.67 | 798 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 11.65 | 44 / 45 |
| heart | 97% | 1841.58 | 838 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 2864.72 | 900 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 14.75 | 28 / 29 |
| eye | 0% | 0 | 0 / 0 | 91% | 14.80 | 73 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045732 | Biological process | positive regulation of protein catabolic process |
| GO_0015031 | Biological process | protein transport |
| GO_0006888 | Biological process | endoplasmic reticulum to Golgi vesicle-mediated transport |
| GO_0048280 | Biological process | vesicle fusion with Golgi apparatus |
| GO_0006890 | Biological process | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum |
| GO_1902902 | Biological process | negative regulation of autophagosome assembly |
| GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
| GO_0012507 | Cellular component | ER to Golgi transport vesicle membrane |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0042470 | Cellular component | melanosome |
| GO_0031201 | Cellular component | SNARE complex |
| GO_0030670 | Cellular component | phagocytic vesicle membrane |
| GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0030133 | Cellular component | transport vesicle |
| GO_0005484 | Molecular function | SNAP receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SEC22B |
| Protein name | Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1) SEC22 vesicle trafficking protein B SEC22 homolog B, vesicle trafficking protein |
| Synonyms | SEC22L1 |
| Description | FUNCTION: SNARE involved in targeting and fusion of ER-derived transport vesicles with the Golgi complex as well as Golgi-derived retrograde transport vesicles with the ER. . FUNCTION: SNARE involved in targeting and fusion of ER-derived transport vesicles with the Golgi complex as well as Golgi-derived retrograde transport vesicles with the ER. . FUNCTION: SNARE involved in targeting and fusion of ER-derived transport vesicles with the Golgi complex as well as Golgi-derived retrograde transport vesicles with the ER. . FUNCTION: SNARE involved in targeting and fusion of ER-derived transport vesicles with the Golgi complex as well as Golgi-derived retrograde transport vesicles with the ER. . |
| Accessions | O75396 I1VE17 I1VE20 I1VE18 ENST00000578049.4 I1VE19 ENST00000618538.1 I1VE16 A0A087X1A9 |